AI/ML Innovations Inc. (AIML.CN)
CAD 0.09
(-10.53%)
CAD 0.09
(-10.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2854.00 CAD | -13.96% |
| 2022 | 3317.00 CAD | -29.2% |
| 2021 | 4685.00 CAD | 167.71% |
| 2020 | 1750.00 CAD | 104.23% |
| 2019 | -41.35 Thousand CAD | -12.27% |
| 2018 | -36.83 Thousand CAD | 46.91% |
| 2017 | -69.38 Thousand CAD | -16.92% |
| 2016 | -59.34 Thousand CAD | -85.17% |
| 2015 | -32.05 Thousand CAD | 85.7% |
| 2014 | -224.09 Thousand CAD | 49.52% |
| 2013 | -443.97 Thousand CAD | 15.12% |
| 2012 | -523.06 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| 1998 | - CAD | 0.0% |
| 1997 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3829.00 CAD | 34.16% |
| 2023 Q1 | 3317.00 CAD | 0.0% |
| 2023 Q4 | 2854.00 CAD | -25.46% |
| 2023 Q3 | 3829.00 CAD | 0.0% |
| 2023 Q2 | 3829.00 CAD | 15.44% |
| 2022 Q1 | 4469.00 CAD | -4.61% |
| 2022 FY | 3317.00 CAD | -29.2% |
| 2022 Q4 | 3317.00 CAD | -1.07% |
| 2022 Q3 | 3353.00 CAD | -1.06% |
| 2022 Q2 | 3389.00 CAD | -24.17% |
| 2021 Q1 | 3082.00 CAD | 76.11% |
| 2021 FY | 4685.00 CAD | 167.71% |
| 2021 Q3 | 3082.00 CAD | 0.0% |
| 2021 Q4 | 4685.00 CAD | 52.01% |
| 2021 Q2 | 3082.00 CAD | 0.0% |
| 2020 Q1 | -68.12 Thousand CAD | -64.71% |
| 2020 FY | 1750.00 CAD | 104.23% |
| 2020 Q2 | - CAD | 100.0% |
| 2020 Q3 | 1750.00 CAD | 0.0% |
| 2020 Q4 | 1750.00 CAD | 0.0% |
| 2019 Q3 | -53.48 Thousand CAD | -18.29% |
| 2019 FY | -41.35 Thousand CAD | -12.27% |
| 2019 Q1 | -48.03 Thousand CAD | -30.39% |
| 2019 Q2 | -45.21 Thousand CAD | 5.87% |
| 2019 Q4 | -41.35 Thousand CAD | 22.68% |
| 2018 FY | -36.83 Thousand CAD | 46.91% |
| 2018 Q2 | -63.18 Thousand CAD | 13.57% |
| 2018 Q1 | -73.1 Thousand CAD | -5.36% |
| 2018 Q4 | -36.83 Thousand CAD | 25.46% |
| 2018 Q3 | -49.42 Thousand CAD | 21.77% |
| 2017 Q1 | -59.47 Thousand CAD | -0.21% |
| 2017 FY | -69.38 Thousand CAD | -16.92% |
| 2017 Q3 | -45.97 Thousand CAD | -0.87% |
| 2017 Q4 | -69.38 Thousand CAD | -50.94% |
| 2017 Q2 | -45.57 Thousand CAD | 23.37% |
| 2016 Q4 | -59.34 Thousand CAD | 17.11% |
| 2016 Q2 | -111.35 Thousand CAD | -243.25% |
| 2016 FY | -59.34 Thousand CAD | -85.17% |
| 2016 Q1 | -32.44 Thousand CAD | -1.22% |
| 2016 Q3 | -71.6 Thousand CAD | 35.7% |
| 2015 Q3 | -243.27 Thousand CAD | -2.74% |
| 2015 FY | -32.05 Thousand CAD | 85.7% |
| 2015 Q4 | -32.05 Thousand CAD | 86.83% |
| 2015 Q2 | -236.79 Thousand CAD | -2.81% |
| 2015 Q1 | -230.31 Thousand CAD | -2.78% |
| 2014 Q3 | -462.41 Thousand CAD | -1.01% |
| 2014 Q2 | -457.78 Thousand CAD | -1.47% |
| 2014 Q1 | -451.13 Thousand CAD | -1.61% |
| 2014 Q4 | -224.09 Thousand CAD | 51.54% |
| 2014 FY | -224.09 Thousand CAD | 49.52% |
| 2013 Q4 | -443.97 Thousand CAD | -2.11% |
| 2013 Q1 | -502.63 Thousand CAD | 3.91% |
| 2013 FY | -443.97 Thousand CAD | 15.12% |
| 2013 Q3 | -434.78 Thousand CAD | 4.4% |
| 2013 Q2 | -454.8 Thousand CAD | 9.52% |
| 2012 Q3 | - CAD | 100.0% |
| 2012 Q2 | -12.62 Thousand CAD | 0.0% |
| 2012 FY | -523.06 Thousand CAD | 0.0% |
| 2012 Q4 | -523.06 Thousand CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2001 Q2 | - CAD | 0.0% |
| 2001 Q1 | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| 2000 Q4 | - CAD | 0.0% |
| 2000 Q3 | - CAD | 0.0% |
| 2000 Q2 | - CAD | 0.0% |
| 2000 Q1 | - CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| 1999 Q4 | - CAD | 0.0% |
| 1999 Q3 | - CAD | 0.0% |
| 1999 Q2 | - CAD | 0.0% |
| 1999 Q1 | - CAD | 0.0% |
| 1998 Q1 | - CAD | 0.0% |
| 1998 Q2 | - CAD | 0.0% |
| 1998 Q3 | - CAD | 0.0% |
| 1998 Q4 | - CAD | 0.0% |
| 1998 FY | - CAD | 0.0% |
| 1997 Q2 | - CAD | 0.0% |
| 1997 Q1 | - CAD | 0.0% |
| 1997 FY | - CAD | 0.0% |
| 1997 Q4 | - CAD | 0.0% |
| 1997 Q3 | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Diagnamed Holdings Corp. | -55.31 CAD | 5260.007% |
| Pangenomic Health Inc. | - CAD | -Infinity% |
| nDatalyze Corp. | - CAD | -Infinity% |
| Treatment.Com International Inc. | - CAD | -Infinity% |
| Unidoc Health Corp. | 32.34 Thousand CAD | 91.176% |